C235H288F25N49O17S2 — CID 157170339
3-[5-(azetidin-1-yl)-3-fluoro-2-pyridinyl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;3-[5-(azetidin-1-yl)-3-fluoro-2-pyridinyl]-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;3-[5-(azetidin-1-yl)-3-methyl-2-pyridinyl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;3-[1-(cyclopropanecarbonyl)-3-(trifluoromethyl)pyrazol-5-yl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;1-(cyclopropylmethyl)-8-ethyl-8-(3-fluorophenyl)-3-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;3-[1-(cyclopropylmethyl)-3-(trifluoromethyl)pyrazol-5-yl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-[1-(2-hydroxyethyl)-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-(5-methylsulfonyl-2-pyridinyl)-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-[1-methylsulfonyl-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;8-(methylamino)-3-(4-methyl-2-morpholin-4-ylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one (PubChem CID 157170339) has the molecular formula C235H288F25N49O17S2 and a molecular weight of 4610.30 g/mol. Its IUPAC name is 3-[5-(azetidin-1-yl)-3-fluoro-2-pyridinyl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;3-[5-(azetidin-1-yl)-3-fluoro-2-pyridinyl]-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;3-[5-(azetidin-1-yl)-3-methyl-2-pyridinyl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;3-[1-(cyclopropanecarbonyl)-3-(trifluoromethyl)pyrazol-5-yl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;1-(cyclopropylmethyl)-8-ethyl-8-(3-fluorophenyl)-3-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;3-[1-(cyclopropylmethyl)-3-(trifluoromethyl)pyrazol-5-yl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-[1-(2-hydroxyethyl)-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-(5-methylsulfonyl-2-pyridinyl)-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-[1-methylsulfonyl-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;8-(methylamino)-3-(4-methyl-2-morpholin-4-ylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one.
| Compound Name | 3-[5-(azetidin-1-yl)-3-fluoro-2-pyridinyl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;3-[5-(azetidin-1-yl)-3-fluoro-2-pyridinyl]-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;3-[5-(azetidin-1-yl)-3-methyl-2-pyridinyl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;3-[1-(cyclopropanecarbonyl)-3-(trifluoromethyl)pyrazol-5-yl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;1-(cyclopropylmethyl)-8-ethyl-8-(3-fluorophenyl)-3-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;3-[1-(cyclopropylmethyl)-3-(trifluoromethyl)pyrazol-5-yl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-[1-(2-hydroxyethyl)-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-(5-methylsulfonyl-2-pyridinyl)-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-[1-methylsulfonyl-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;8-(methylamino)-3-(4-methyl-2-morpholin-4-ylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one |
|---|---|
| PubChem CID | 157170339 |
| Molecular Formula | C235H288F25N49O17S2 |
| Molecular Weight | 4610.30 g/mol |
| Exact Mass | 4607.22 |
| IUPAC Name | 3-[5-(azetidin-1-yl)-3-fluoro-2-pyridinyl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;3-[5-(azetidin-1-yl)-3-fluoro-2-pyridinyl]-8-(dimethylamino)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one;3-[5-(azetidin-1-yl)-3-methyl-2-pyridinyl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;3-[1-(cyclopropanecarbonyl)-3-(trifluoromethyl)pyrazol-5-yl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;1-(cyclopropylmethyl)-8-ethyl-8-(3-fluorophenyl)-3-[1-methyl-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;3-[1-(cyclopropylmethyl)-3-(trifluoromethyl)pyrazol-5-yl]-8-(dimethylamino)-8-(3-fluorophenyl)-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-[1-(2-hydroxyethyl)-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-(5-methylsulfonyl-2-pyridinyl)-1,3-diazaspiro[4.5]decan-2-one;8-(dimethylamino)-8-(3-fluorophenyl)-3-[1-methylsulfonyl-3-(trifluoromethyl)pyrazol-5-yl]-1,3-diazaspiro[4.5]decan-2-one;8-(methylamino)-3-(4-methyl-2-morpholin-4-ylpyrimidin-5-yl)-8-phenyl-1,3-diazaspiro[4.5]decan-2-one |
| SMILES | CCC1(c2cccc(F)c2)CCC2(CC1)CN(c1cc(C(F)(F)F)nn1C)C(=O)N2CC1CC1.CN(C)C1(c2cccc(F)c2)CCC2(CC1)CN(c1cc(C(F)(F)F)nn1C(=O)C1CC1)C(=O)N2.CN(C)C1(c2cccc(F)c2)CCC2(CC1)CN(c1cc(C(F)(F)F)nn1CC1CC1)C(=O)N2.CN(C)C1(c2cccc(F)c2)CCC2(CC1)CN(c1cc(C(F)(F)F)nn1CCO)C(=O)N2.CN(C)C1(c2cccc(F)c2)CCC2(CC1)CN(c1cc(C(F)(F)F)nn1S(C)(=O)=O)C(=O)N2.CN(C)C1(c2cccc(F)c2)CCC2(CC1)CN(c1ccc(S(C)(=O)=O)cn1)C(=O)N2.CN(C)C1(c2cccc(F)c2)CCC2(CC1)CN(c1ncc(N3CCC3)cc1F)C(=O)N2.CN(C)C1(c2ccccc2)CCC2(CC1)CN(c1ncc(N3CCC3)cc1F)C(=O)N2.CNC1(c2ccccc2)CCC2(CC1)CN(c1cnc(N3CCOCC3)nc1C)C(=O)N2.Cc1cc(N2CCC2)cnc1N1CC2(CCC(c3cccc(F)c3)(N(C)C)CC2)NC1=O |
| InChI | InChI=1S/C25H30F4N4O.C25H32FN5O.C24H27F4N5O2.C24H29F4N5O.C24H29F2N5O.C24H30FN5O.C24H32N6O2.C22H27F4N5O2.C22H27FN4O3S.C21H25F4N5O3S/c1-3-23(18-5-4-6-19(26)13-18)9-11-24(12-10-23)16-32(22(34)33(24)15-17-7-8-17)21-14-20(25(27,28)29)30-31(21)2;1-18-14-21(30-12-5-13-30)16-27-22(18)31-17-24(28-23(31)32)8-10-25(11-9-24,29(2)3)19-6-4-7-20(26)15-19;1-31(2)23(16-4-3-5-17(25)12-16)10-8-22(9-11-23)14-32(21(35)29-22)19-13-18(24(26,27)28)30-33(19)20(34)15-6-7-15;1-31(2)23(17-4-3-5-18(25)12-17)10-8-22(9-11-23)15-32(21(34)29-22)20-13-19(24(26,27)28)30-33(20)14-16-6-7-16;1-29(2)24(17-5-3-6-18(25)13-17)9-7-23(8-10-24)16-31(22(32)28-23)21-20(26)14-19(15-27-21)30-11-4-12-30;1-28(2)24(18-7-4-3-5-8-18)11-9-23(10-12-24)17-30(22(31)27-23)21-20(25)15-19(16-26-21)29-13-6-14-29;1-18-20(16-26-21(27-18)29-12-14-32-15-13-29)30-17-23(28-22(30)31)8-10-24(25-2,11-9-23)19-6-4-3-5-7-19;1-29(2)21(15-4-3-5-16(23)12-15)8-6-20(7-9-21)14-30(19(33)27-20)18-13-17(22(24,25)26)28-31(18)10-11-32;1-26(2)22(16-5-4-6-17(23)13-16)11-9-21(10-12-22)15-27(20(28)25-21)19-8-7-18(14-24-19)31(3,29)30;1-28(2)20(14-5-4-6-15(22)11-14)9-7-19(8-10-20)13-29(18(31)26-19)17-12-16(21(23,24)25)27-30(17)34(3,32)33/h4-6,13-14,17H,3,7-12,15-16H2,1-2H3;4,6-7,14-16H,5,8-13,17H2,1-3H3,(H,28,32);3-5,12-13,15H,6-11,14H2,1-2H3,(H,29,35);3-5,12-13,16H,6-11,14-15H2,1-2H3,(H,29,34);3,5-6,13-15H,4,7-12,16H2,1-2H3,(H,28,32);3-5,7-8,15-16H,6,9-14,17H2,1-2H3,(H,27,31);3-7,16,25H,8-15,17H2,1-2H3,(H,28,31);3-5,12-13,32H,6-11,14H2,1-2H3,(H,27,33);4-8,13-14H,9-12,15H2,1-3H3,(H,25,28);4-6,11-12H,7-10,13H2,1-3H3,(H,26,31) |
| InChIKey | ANJUGNQWVSXKHV-UHFFFAOYSA-N |
| XLogP | 38.65 |
| TPSA | 646.77 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 46 |
| Rotatable Bonds | 43 |
| Heavy Atoms | 328 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4610.30 |
| LogP ≤ 5 | 38.65 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 46 |